Chronic myeloid leukaemia trials in Saudi Arabia

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Asciminib Roll-over Study

  Where

  Riyadh

  Age

  7 years to 100 years

  People

  347 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04877522 · EU 2023-507557-16-00
• No phaseTaking people
  RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

  Where

  Dammam, Jeddah, Riyadh

  Age

  18 years to 99 years

  People

  40

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06684964